SCHEMBL7744177

SCHEMBL7744177

CC(=O)Nc1oc(-c2ncccc2-c2cccc(Cl)c2)nc1-c1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 7/20 0.67
FLT1 P17948 1/20 0.56
FLT4 P35916 1/20 0.56
RORB Q92753 1/20 0.44
ADORA1 P30542 2/20 0.44
HSP90AA1 P07900 1/20 0.43
HSP90AB1 P08238 1/20 0.43
S100A4 P26447 1/20 0.42
MAPT P10636 1/20 0.42
CNR2 P34972 2/20 0.41
ABL1 P00519 1/20 0.41
PTGER1 P34995 1/20 0.40
NR4A2 P43354 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
ALOX15 P16050 1/20 0.39
RXRA P19793 1/20 0.39
RXRB P28702 1/20 0.39
RXRG P48443 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7746644 0.89 KDR (0.62) KDRFLT1FLT4S100A4MAPT
SCHEMBL7738998 0.89 KDR (0.57) KDRFLT1FLT4ADORA1NR4A2
SCHEMBL7744174 0.88 KDR (0.66) KDRFLT1FLT4ADORA1S100A4
SCHEMBL7739021 0.86 KDR (0.67) KDRFLT1FLT4ADORA1HSP90AA1
SCHEMBL7744677 0.85 KDR (0.53) KDRFLT1FLT4RORBADORA1
SCHEMBL7746657 0.84 KDR (0.53) KDRFLT1FLT4MAPTALDH1A1
SCHEMBL7739080 0.80 KDR (0.62) KDRFLT1FLT4ADORA1HSP90AA1
SCHEMBL7739078 0.78 KDR (0.68) KDRFLT1FLT4HSP90AA1HSP90AB1
SCHEMBL7739089 0.76 KDR (0.60) KDRFLT1FLT4HSP90AA1HSP90AB1
SCHEMBL7744668 0.76 KDR (0.69) KDRFLT1FLT4ADORA1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed